BioSpace News Archive

Corn — or maize — has changed over thousands of years from weedy plants that make ears with less than a dozen kernels to the cobs packed with hundreds of juicy kernels that we see on farms

Paragonix Technologies, the leading hypothermic cardiothoracic organ preservation provider, announced today the first-in-man clinical use of the only FDA cleared cold storage device for donor lungs, its LUNGguard™ Donor Lung Preservation System, by Duke University Hospital.

American Heart Association announces EmPOWERED to Serve™ Black Women and Well-Being Roundtable in partnership with Divine Nine Sororities and The Links, Inc.

Octapharma announced today that the final results from the NuProtect study on the immunogenicity of Nuwiq ® in previously untreated patients (PUPs) with severe haemophilia A have been published in the leading medical journal Thrombosis and Haemostasis

SHEPHERD Therapeutics, a company dedicated to catalyzing lifesaving treatments for rare cancer patients, today announced a collaboration with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

SteriPack Group, a leading global contract manufacturing service provider to the medical device, diagnostic and pharmaceutical industries, has acquired Morristown, NJ-based HS Design Inc.

Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that it will report financial results and provide an update on recent progress on its development programs pre-market on March 1, 2021.

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will present a company overview at the following upcoming virtual investor conferences: H.C. Wainwright Global Life Sciences Conference. Tuesday, March 9, 2021 at 7:00 a.m. ET.

Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today the expansion of its clinical collaboration agreement with Bristol Myers Squibb.

Hope Biosciences Stem Cell Research Foundation, administered through the Greater Houston Community Foundation, was founded to address the need to accelerate translational research in regenerative medicine so that therapies could be delivered to patients faster.